From patients to disease: the difficult case of Alzheimer's
暂无分享，去创建一个
[1] Nick C Fox,et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study , 2022, The Lancet Neurology.
[2] K. Blennow,et al. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised , 2021, Nature Reviews Neuroscience.
[3] Justin S. Sanchez,et al. In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease , 2021, Science advances.
[4] Derek H. Oakley,et al. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease , 2020, Nature Medicine.
[5] G. Logroscino,et al. A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease , 2019, Nature Reviews Neurology.